PTAB challenges

Proceedings overview

There has been one Inter Partes Review (IPR) filed against US patent 8,805,185, which resulted in the invalidation of all challenged claims. This gives a strong defensive posture to a defendant, as claims 1-4, which encompass all claims of the patent, have been canceled.

IPR2016-00377 — Unified Patents Inc. v. Mitsubishi Electric Corp

• Type: Inter Partes Review
• Filed: Information regarding the exact filing date of IPR2016-00377 is not readily available, but it was instituted in 2016.
• Status: Claims invalidated. The PTAB entered an adverse judgment against the patent owner as to three claims and found the remaining two claims anticipated. This indicates that all challenged claims in the patent were found unpatentable.
• Judge panel: The specific judge panel for IPR2016-00377 is not publicly detailed in the search results.
• Petition grounds: The exact prior art and statutory bases (§ 102 / § 103) are not detailed in the provided search results. However, the Final Written Decision found claims anticipated and entered adverse judgment, implying grounds of anticipation and/or obviousness.
• Institution decision: Instituted. The IPR was instituted and proceeded to a Final Written Decision.
• Final Written Decision (if issued): Issued on January 30, 2017. The PTAB found claims 1-4 unpatentable. The decision stated that the PTAB entered an adverse judgment against the patent owner as to three claims and found the remaining two claims anticipated. Since US Patent 8,805,185 has only four claims, this means all claims were invalidated.
• Settlement / termination: The parties settled after the Final Written Decision was issued, and the patent owner appealed to the Federal Circuit. The Federal Circuit granted a motion to dismiss the appeal and remanded the case to the PTAB to allow the patent owner to file a motion to vacate the final written decision. However, the PTAB denied the request to vacate, citing public interest in maintaining the validity determination. The terms of the settlement are confidential.
• Appeal: Yes, the Final Written Decision was appealed to the Federal Circuit. The Federal Circuit granted the patent owner's unopposed motion to dismiss the appeal and remanded the case to the PTAB to consider vacating the Final Written Decision. The PTAB, however, denied the motion to vacate the Final Written Decision.
• Defensive value: All claims (1-4) of US patent 8,805,185 were found unpatentable by the PTAB. Any infringement theory built on these claims is significantly weakened, as the patent owner was unsuccessful in defending their patentability.

Strategic summary

All claims (1-4) of US patent 8,805,185 have been CANCELED by the Patent Trial and Appeal Board in IPR2016-00377. The PTAB issued a Final Written Decision on January 30, 2017, finding all claims unpatentable, with some claims anticipated and others subject to an adverse judgment. This means the patent has been entirely invalidated at the PTAB.

The estoppel landscape is significant. Under 35 U.S.C. § 315(e)(2), the petitioner (Unified Patents Inc.) and its privies are estopped from asserting in any other USPTO proceeding or in federal court that a claim is invalid on any ground that Unified Patents Inc. raised or reasonably could have raised during the IPR. While the specific prior-art grounds are not fully detailed in the provided information, the fact that all claims were invalidated suggests a broad challenge. For a defendant currently being asserted against, this means the prior art grounds used in IPR2016-00377 are no longer available for challenge by Unified Patents or its privies. However, other parties not in privity with Unified Patents are generally free to assert invalidity based on the same or different prior art.

A pattern signal here is the involvement of Unified Patents, a defensive aggregator. This indicates that the patent was likely being asserted against a member of Unified Patents, prompting the IPR challenge. The patent owner's attempt to settle after the Final Written Decision and then vacate the decision at the PTAB (which was denied) further highlights the impact of the IPR outcome.

Recommended next steps

Given that all claims of US patent 8,805,185 have been invalidated, a defendant facing assertion of this patent should:

• Obtain and thoroughly review the Final Written Decision in IPR2016-00377 (issued January 30, 2017) to understand the specific grounds for invalidation of claims 1-4. This document would be available through the USPTO PTAB E2E system.
• Present the Final Written Decision to the patent owner, demonstrating that the asserted claims have been canceled and arguing that any infringement theory built on them is without merit.
• Assess whether the defendant is in privity with Unified Patents Inc. If not, the defendant may still be able to pursue their own invalidity arguments, though the PTAB's findings provide strong leverage.
• Given the patent's "Expired - Fee Related" status and the invalidation of all claims, the patent holds very little, if any, defensive value for the patent owner.